The Lancet warns of 'overlooked pandemic of antimicrobial resistance' in new study
The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.
In a new study published this week, The Lancet analysed deaths associated with bacterial AMR for 23 pathogens and 88 pathogen–drug combinations in 204 countries and territories in 2019.
The findings estimate there were 4·95 million deaths in 2019 directly attributable to resistance, nearly the same as global HIV deaths and malaria deaths combined, second only to mortality from COVID-19 and tuberculosis in terms of global deaths from infectious diseases.
Antimicrobial resistance (AMR) occurs when changes in bacteria cause the drugs used to treat infections to become less effective, often through either misuse or overuse.
This poses a great risk to future public health, and may create a scenario where once routine procedures become complex and dangerous. The WHO states that 'without effective antimicrobials for prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, diabetes management and major surgery become very high-risk.'1
The European Commission also estimates that AMR costs the EU €1.5 billion per year in healthcare costs and productivity losses.2
Innovation and action are needed to address the challenges of AMR. The Lancet states that 'spending needs to be directed to preventing infections in the first place, making sure existing antibiotics are used appropriately and judiciously, and to bringing new antibiotics to market. Health and political leaders at local, national, and international levels need to take seriously the importance of addressing AMR and the challenge of poor access to affordable, effective antibiotics.'3
Related News
-
News 5 big pharma companies agree to decarbonise operations in China
Following extensive talks, leading pharmaceutical companies sign an agreement to work with renewable energy companies to decarbonise their manufacturing supply chains in China and switch to renewables. -
News CPHI Podcast Series: The 2023 Retro – what have we learnt from the past year in pharma?
Welcome to the last episode of 2023! Digital Editor Lucy Chard is joined by her teammates in a special retrospective episode to close out the year. Guests Vivian Xie, Editor for CPHI Online and Tara Dougal, Content Director for Pharma, discuss their hi... -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Barcelona 2023 – From the Floor
It's that time of year again - the biggest pharma event of the year comes to Spain this October for CPHI Barcelona 2023. Follow our Editors Vivian Xie and Lucy Chard as they worked their way through the conference, bringing highlights from content ... -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News CPHI Barcelona Sustainability Partner Interview – Procaps' improvement through innovation
Procaps, developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents, has partnered with CPHI Barcelona to support sustainability initiatives, to be highlighted at t... -
News The future of robotics in pharma: drug discovery to manufacturing
Robotics are starting to play a key role in the discovery and manufacturing of health and drug products, with numerous benefits, from cost reduction to increased sustainability, but there are challenges as well. -
News CPHI Barcelona Sustainability Partner Interview – Rontis' mindful management
Rontis Corporation, a leading supplier in the healthcare industry worldwide, has partnered with CPHI Barcelona to support sustainability initiatives, to be highlighted at the CPHI Worldwide event in Barcelona in October 2023.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance